Feng Shu, Bogatcheva Natalia V, Truong Anne, Korchin Borys, Bishop Colin E, Klonisch Thomas, Agoulnik Irina U, Agoulnik Alexander I
Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030, USA.
Biol Reprod. 2007 Oct;77(4):671-80. doi: 10.1095/biolreprod.107.060442. Epub 2007 Jul 5.
The mutations of testicular insulin-like 3 (INSL3) hormone or its receptor RXFP2 cause cryptorchidism in male mice. Here we have examined Rxfp2 gene expression at different stages of embryonic and postnatal mouse development in male reproductive tissues employing quantitative RT-PCR and several RXFP2-specific antibodies directed toward different parts of the RXFP2 protein. Receptor expression was markedly increased after birth and was readily detectable in the epididymis, Leydig cells, and germ cells of the testis. The strongest expression was detected in adult mouse cremaster muscle. INSL3 treatment increased cell proliferation of embryonic gubernacular and TM3 embryonic Leydig cells, implicating active INSL3-mediated autocrine signaling in these cells and identifying TM3 as a novel in vitro model to study the effects of RXFP2 signaling. We generated Tg(Rxfp2-cre)Aia (Rxfp2-iCre) transgenic mice expressing improved Cre recombinase (iCre) under the control of the 2.4-kb mouse Rxfp2 promoter. The iCre was expressed in the gubernacular ligament at E14.5, indicating that this promoter is able to drive Rxfp2 gene expression during transabdominal testis descent. We demonstrated that the transcription factor Sox9, a known male sex determination factor, is expressed in mouse embryonic gubernacula and upregulated human, but not mouse, promoter luciferase reporter constructs. In conclusion, we have determined the developmental expression profile of INSL3 receptor employing newly characterized RXFP2 antisera and a novel Rxfp2-iCre transgenic mouse model. We determined the promoter region capable of providing the gubernacular-specific expression of Rxfp2. Analysis of RXFP2 promoter identified SOX9 as a new transcriptional enhancer of human gene expression.
睾丸胰岛素样 3(INSL3)激素或其受体 RXFP2 的突变会导致雄性小鼠隐睾症。在此,我们利用定量逆转录聚合酶链反应(RT-PCR)以及几种针对 RXFP2 蛋白不同部位的 RXFP2 特异性抗体,检测了雄性生殖组织中 Rxfp2 基因在小鼠胚胎期和出生后不同发育阶段的表达情况。出生后受体表达显著增加,在附睾、睾丸间质细胞和生殖细胞中易于检测到。在成年小鼠提睾肌中检测到最强的表达。INSL3 处理增加了胚胎引带和 TM3 胚胎睾丸间质细胞的细胞增殖,这表明这些细胞中存在活跃的 INSL3 介导的自分泌信号,并将 TM3 确定为研究 RXFP2 信号传导作用的新型体外模型。我们构建了 Tg(Rxfp2-cre)Aia(Rxfp2-iCre)转基因小鼠,其在 2.4 kb 小鼠 Rxfp2 启动子的控制下表达改良型 Cre 重组酶(iCre)。在胚胎第 14.5 天,iCre 在引带韧带中表达,这表明该启动子能够在经腹睾丸下降过程中驱动 Rxfp2 基因表达。我们证明转录因子 Sox9(一种已知的雄性性别决定因子)在小鼠胚胎引带中表达,并上调人而非小鼠的启动子荧光素酶报告基因构建体。总之,我们利用新鉴定的 RXFP2 抗血清和新型 Rxfp2-iCre 转基因小鼠模型确定了 INSL3 受体的发育表达谱。我们确定了能够提供 Rxfp2 引带特异性表达的启动子区域。对 RXFP2 启动子的分析确定 SOX9 为人类基因表达的新转录增强子。